S. Melmed, U.B. Kaiser, M.B. Lopes et al. Clinical biology of the pituitary adenoma. Endocr. Rev. 43, 1003–1037 (2022)
Article PubMed PubMed Central Google Scholar
A.F. Daly, A. Beckers, The epidemiology of pituitary adenomas. Endocrinol. Metab. Clin. North. Am. 49, 347–355 (2020)
S. Vandeva, A.F. Daly, P. Petrossians, S. Zacharieva, A. Beckers, Somatic and germline mutations in the pathogenesis of pituitary adenomas. Eur. J. Endocrinol. 181, R235–R254 (2019)
Article CAS PubMed Google Scholar
G. Trivellin, A.F. Daly, L.C. Hernández-Ramírez et al. Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion. Front. Endocrinol. 14, 1166076 (2023)
P. Xekouki, A. Brennand, B. Whitelaw, K. Pacak, C.A. Stratakis, The 3PAs: an update on the association of pheochromocytomas, paragangliomas, and pituitary tumors. Horm. Metab. Res. 51, 419–436 (2019)
Article CAS PubMed Google Scholar
S.M. O’Toole, J. Dénes, M. Robledo, C.A. Stratakis, M. Korbonits, The association of pituitary adenomas and phaeochromocytomas or paragangliomas. Endocr. Relat. Cancer 22, T105–T122 (2015)
I. Comino-Méndez, F.J. Gracia-Aznárez, F. Schiavi et al. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat. Genet. 43, 663–667 (2011)
E.M. Blackwood, R.N. Eisenman, Max: a Helix-Loop-Helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251, 1211–1217 (1991)
Article CAS PubMed Google Scholar
A. Augert, H. Mathsyaraja, A.H. Ibrahim et al. MAX Functions as a tumor suppressor and rewires metabolism in small cell lung cancer. Cancer Cell 38, 97–114.e7 (2020)
Article CAS PubMed PubMed Central Google Scholar
M.A. Pantaleo, M. Urbini, V. Indio et al. Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST. Mol. Cancer Res. 15, 553–562 (2017)
Article CAS PubMed Google Scholar
E. Korpershoek, D. Koffy, B.H. Eussen et al. Complex MAX rearrangement in a family with malignant pheochromocytoma, renal oncocytoma, and erythrocytosis. J. Clin. Endocrinol. Metab. 101, 453–460 (2016)
Article CAS PubMed Google Scholar
A.F. Daly, E. Castermans, L. Oudijk et al. Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions. Endocr. Relat. Cancer 25, L37–L42 (2018)
Article CAS PubMed Google Scholar
A.J. Seabrook, J.E. Harris, S.B. Velosa et al. Multiple endocrine tumors associated with germline MAX mutations: multiple endocrine neoplasia type 5? J. Clin. Endocrinol. Metab. 106, 1163–1182 (2021)
P.B. Loughrey, F. Roncaroli, E. Healy, P. Weir, M. Basetti, R.T. Casey, S.J. Hunter, M. Korbonits, Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours. Endocr. Relat. Cancer 29(10), R157–R172 (2022). https://doi.org/10.1530/ERC-22-0157
Article CAS PubMed PubMed Central Google Scholar
S. Petignot, A.F. Daly, E. Castermans, E. Korpershoek, I. Scagnol, P. Beckers, V. Dideberg, V. Rohmer, V. Bours, A. Beckers, Pancreatic neuroendocrine neoplasm associated with a familial MAX deletion. Horm. Metab. Res. 52, 784–787 (2020)
Article CAS PubMed Google Scholar
Clifton-Bligh R., Mete O., Fuchs T.L. Genetic tumour syndromes. WHO Classification of Tumours online (2024)
A. Beckers, P. Petrossians, J. Hanson, A.F. Daly, The causes and consequences of pituitary gigantism. Nat. Rev. Endocrinol. 14, 705–720 (2018)
Article CAS PubMed Google Scholar
Á. Decmann, P. Perge, M. Tóth, P. Igaz, Adrenal myelolipoma: a comprehensive review. Endocrine 59, 7–15 (2018)
Article CAS PubMed Google Scholar
A. Haider, O. Symczyk, A. Hardy, A. Kothapalli, Testicular adrenal rest cells in congenital adrenal hyperplasia. J. Clin. Transl. Endocrinol. Case Rep. 22, 100103 (2021)
G. Mougel, A. Lagarde, F. Albarel et al. Germinal defects of SDHx genes in patients with isolated pituitary adenoma. Eur. J. Endocrinol. 183, 369–379 (2020)
Comments (0)